FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Instagram Outage Disrupts Thousands of U.S. Users 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SAN CLEMENTE, Calif., March 27, 2017 -- David Steenblock, D.O., an osteopathic physician based in San Clemente, CA, uses hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. He is one of the country’s leading practitioners in the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.
“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ says Dr. Steenblock. He encourages U.S. physicians to consider the merits of this approach.
Dr. Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments--within 12 weeks--in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.
The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Dr. Steenblock explains. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.
After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.
Dr. David Steenblock is a leading-edge physician in many fields of medicine, from stroke care, to acute brain trauma, to generative and cell-based medicine in the treatment of ALS, Cerebral Palsy and other chronic and degenerative diseases. For more information about Dr. Steenblock’s work in stroke therapy, visit www.stemcellmd.org
Irene Doti [email protected]
